BONTAC úspešne usporiadal 60. Viceprezidentský salón zdravotníckeho priemyslu v Shenzhen
Úvod
Dňa 26. júla 2024 BONTAC spolu s Asociáciou na podporu rozvoja zdravotníctva v Shenzhen úspešne usporiadali 60. Viceprezidentský salón zdravotníckeho priemyslu Shenzhen s témou "Zelené biotechnológie, vytváranie zdravého a lepšieho života".This event was professionally guided by the Joint Party Committee of Related Associations in Shenzhen Health Industry and Shenzhen Health Care Association, as well as strongly supported by Shenzhen Social Organization Exchange Service Exhibition Site.
Pod vedením pani Huang, výkonnej riaditeľky Shenzhen Healthcare Industry Development Promotion Association, sa zišlo viac ako 40 členov, aby preskúmali vznikajúce trendy a inovatívne príležitosti v zdravotníckom priemysle.
Advancing Biotechnology and Shaping the Health Industry's Future
As the event commenced, participants were first guided through BONTAC's exhibition hall, where they were granted an enriched and comprehensive insight into the company's developmental journey, robust R&D strength, and innovative product lineup.
Subsequently, at the symposium, Dr. Cheung, BONTAC Chief Scientist, gave a keynote speech titled "Efficient and Green Biosynthesis of Natural Products Such as Ginsenosid and NMN”, delving into the profound applications and promising future of synthetic biology in the sustainable production of natural compounds like ginsenoside and NMN. Afterwards, Mr. Zhang, BONTAC’s Director of Development Strategy, outlined the company's current trajectory and future aspirations, articulating a grand vision for collaborative innovation with diverse partners to advance the frontiers of biotechnology.
Pán Wu, uznávaný právnik z kancelárie Shenzhen v Pekingu Jingsh, poskytol členským spoločnostiam cenné poznatky prostredníctvom hĺbkovej analýzy kľúčových faktorov pre medzinárodnú expanziu čínskych farmaceutických podnikov a zdravotníckych produktov, so zameraním na duševné vlastníctvo a regulačnú súlad.
Počas interaktívnych sedení účastníci viedli hlboké diskusie o kľúčových témach, vrátane aplikácie syntetickej biotechnológie a globálnych expanzných stratégií podnikov. Dr. Cheung poskytol podrobné odpovede na súvisiace otázky.
Meanwhile, the Association's inaugural council for 2024 took place at BONTAC. Ms. Huang reviewed the accomplishments of the first half of the year and outlined the strategic priorities for the latter half, which encompass organizing the Shenzhen Health Conference, releasing the industry's development report, and advancing the establishment of group standards. These initiatives are poised to amplify the Association's impact and foster the health industry's sustainable growth.
After a group photo session, the guests engaged in a profound dialogue with the BONTAC team at the conclusion of the event. This interaction not only provided them with a deeper insight into BONTAC's high-quality products, but also enhanced their appreciation of the company's innovative ethos and product strengths. Concurrently, the event infused new energy and momentum into the health industry's ongoing innovation and advancement.
Vízia do budúcnosti
Moving forward, BONTAC remains committed to the philosophy of 'Green Bio-Tech, creating a healthy and better life”, pushing the development of synthetic biology and making significant contributions in the realm of human health. We are looking forward to collaborating with a broader array of partners to open a new and vibrant chapter in the health industry.
O BONTAC
As a pioneering force in the NMN industry, BONTAC stands as a national high-tech enterprise integrating R&D, production, and sales around synthetic biotechnology with bio-enzyme catalysis at its core. Notably, BONTAC boasts the world's first whole-enzyme technology and has achieved two 'firsts': pioneering mass production of NMN and NMNH, and being the first in China to synthesize rare natural products like ginsenosides, steviosides, and salidroside. Furthermore, BONTAC has established the inaugural and sole provincial coenzyme engineering technology research center in Guangdong China, significantly contributing to the advancement of synthetic biology.
.jpg?imageView2/1/w/360/h/200)
